Actions of non-steroidal anti-inflammatory drugs on equine leucocyte movement in vitro
Article first published online: 17 APR 2008
Journal of Veterinary Pharmacology and Therapeutics
Volume 10, Issue 2, pages 150–159, June 1987
How to Cite
DAWSON, J., LEES, P. and SEDGWICK, A. D. (1987), Actions of non-steroidal anti-inflammatory drugs on equine leucocyte movement in vitro. Journal of Veterinary Pharmacology and Therapeutics, 10: 150–159. doi: 10.1111/j.1365-2885.1987.tb00092.x
- Issue published online: 17 APR 2008
- Article first published online: 17 APR 2008
Dawson, J., Lees, P. & Sedgwick, A.D. Actions of non-steroidal antiinflammatory drugs on equine leucocyte movement in vitro. J. vet. Pharmacol. Therap. 10, 150–159.
The direct effects of four non-steroidal anti-inflammatory drugs (NSAIDs) on equine polymorphonuclear (PMN) and mononuclear (MN) leucocyte movement were investigated using two in vitro assay systems. The Boyden chamber microfilter technique measures both chemokinetic and chemotactic locomotion, and the agarose microdroplet assay measures solely chemokinesis. Zymosan-activated plasma (ZAP) and the synthetic peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) were used as standard chemoattractants for PMN and MN leucocytes, respectively. The actions of six concentrations of each NSAID, indomethacin (50 μM–10 mM), phenylbutazone (10 μM–1 mM), oxyphenbutazone (2.5 μM–500 μM) AND flunixin (0.1 μw–50 μM), in suppressing cell movement induced by ZAP and FMLP were investigated. All four drugs exerted inhibitory effects on induced movement of both cell types in the Boyden chamber assay, usually in a concentration-dependent manner, although oxyphenbutazone action on PMN cells occurred only at the highest concentration tested. Significant inhibition of PMN and MN cell locomotion was produced by indomethacin, flunixin and oxyphenbutazone, and inhibition of PMN movement by phenylbutazone occurred in the agarose microdroplet assay. Flunixin was the most potent of the four drugs investigated in both assay systems. The findings may be of importance to the use of phenylbutazone and flunixin as NSAIDs in equine medicine, since the concentrations used were similar to concentrations of both drugs and the phenylbutazone metabolite oxyphenbutazone previously reported to occur in equine plasma and inflammatory exudate.